Metraipolis › archive › dc_361af8539b45

Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective — Europe PMC PMID:42136641

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42136641
DOI
10.3389/fimmu.2026.1769281
License (as archived)
solo-consultazione
Archived
2026-11-02T23:06:35.991Z
SHA-256 of the archived text
840bfe89624427f6b0d14c7fec95f4453452c00d8f77898eee2f16430df56907
Stable URL of this page
https://metraipolis.com/documento/dc_361af8539b45

How to cite

Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective — Europe PMC PMID:42136641 — Europe PMC (en), https://europepmc.org/article/MED/42136641 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_361af8539b45 (Metraipolis archive dc_361af8539b45, sha256 840bfe89624427f6b0d14c7fec95f4453452c00d8f77898eee2f16430df56907)
BibTeX
@misc{dc361af8539b45,
  title = {Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective — Europe PMC PMID:42136641},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42136641},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_361af8539b45; sha256 840bfe89624427f6b0d14c7fec95f4453452c00d8f77898eee2f16430df56907},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42136641. Agents can read the archived copy with the MCP tool read_document.